Cytek Biosciences Inc (CTKB)
Operating profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -20,523 | -23,646 | -25,818 | -26,418 | -27,846 | -27,625 | -18,706 | -10,470 | -665 | 578 | 1,151 | 5,853 | 9,342 | 15,891 | 19,530 | 15,501 | 13,659 |
| Revenue (ttm) | US$ in thousands | 176,629 | 201,210 | 197,710 | 200,786 | 193,014 | 183,117 | 175,594 | 166,060 | 164,036 | 154,594 | 148,493 | 138,742 | 127,950 | 119,675 | 110,395 | 99,123 | 92,839 |
| Operating profit margin | -11.62% | -11.75% | -13.06% | -13.16% | -14.43% | -15.09% | -10.65% | -6.30% | -0.41% | 0.37% | 0.78% | 4.22% | 7.30% | 13.28% | 17.69% | 15.64% | 14.71% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-20,523K ÷ $176,629K
= -11.62%
The operating profit margin of Cytek Biosciences Inc has shown a declining trend over the past few years, starting at 14.71% in December 2020 and dropping to -11.62% by December 2024. This indicates that the company's ability to generate profits from its core operations has deteriorated significantly. A decreasing operating profit margin could be attributed to various factors such as increasing operating expenses, declining sales revenue, or inefficient cost management. It is essential for the company to closely monitor and address the factors contributing to this decline to improve its financial performance and ensure long-term sustainability.
Peer comparison
Dec 31, 2024